Panel Discusses Financing of Transformative Therapies
June 10, 2020
A panel discussion offers multiple perspectives into the requirements and challenges involved with value-based contracting models for transformative therapies.
The on-demand discussion, moderated by Aetion’s Maya Tsukernik, is part of BIO Digital 2020.
Featured speakers include:
- Doug Danison, bluebird bio;
- Neal Masia, Health Capital Group;
- Cristina Masseria, Pfizer; and
- Steve Miller, Cigna Corporation.
To learn more about this discussion, click here.